Emergent BioSolutions, a Gaithersburg, Maryland-headquartered specialty pharmaceutical company and contract manufacturer, has announced executive management changes.

The company’s Board of Directors has promoted Robert G. Kramer Sr. to the newly-created position of President and Chief Operating Officer (COO), and appointed Richard S. Lindahl as the company’s new Executive Vice President and Chief Financial Officer (CFO).

As president and COO, Kramer will have responsibility for the company’s day-to-day operations and the execution of the company’s stated growth plan. He will report directly to the company’s Chief Executive Officer, Daniel J. Abdun-Nabi. Kramer joined the company in early 1999 shortly after its founding. Over the years, he has held a variety of executive-level positions, including President of Emergent’s Lansing, Michigan manufacturing site and, most recently, Executive Vice President, Administration and Chief Financial Officer.

Lindahl joins the company with responsibility for financial operations, investor relations, and information technology. He will also report to Abdun-Nabi. Lindahl most recently served as CFO at CEB, a best-practice insight and technology company, where he developed the finance organization to effectively support the company’s growth, resulting in a four-fold increase in market capitalization over his eight-year tenure. Prior to CEB, he served as Senior Vice President and Treasurer of Sprint Nextel Corporation, Vice President and Treasurer of Nextel Communications, and in progressive finance and management positions at Nextel, Pocket Communications, MCI Communications Corp., Deloitte & Touche LLP, and Casher Associates, Inc.

Source: Emergent BioSolutions